ACell, Inc.

Equities

ACLL

US00444J1025

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2021	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
2020	ACell, Inc. Announces CE Mark Approval	CI

ACell, Inc. Announces CE Mark Approval

December 22, 2020 at 07:45 am EST

ACell, Inc. announced that it has received CE mark approval for its MicroMatrix®, Cytal® Wound Matrix, and Cytal® Burn Matrix devices. This regulatory approval allows ACell to distribute these products throughout the 27 countries of the European Union.

Latest news about ACell, Inc.

Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	21-01-19	CI
ACell, Inc. Announces CE Mark Approval	20-12-22	CI
Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.	20-12-15	CI
ACell, Inc. has withdrawn its IPO in the amount of $80 million.	20-07-20	CI
ACell, Inc. has filed an IPO in the amount of $86.25 million.	20-06-26	CI
ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana	19-09-05	CI
ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products	19-09-04	CI
ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd	19-04-08	CI
ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix	18-10-15	CI
ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias	18-10-08	CI
ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center	18-07-20	CI
ACell, Inc. Names Nino Pionati as Vice President, International and Business Development	18-05-08	CI
ACell, Inc. Announces Launch of Gentrix® Incisional	18-04-11	CI
ACell, Inc. Announces New Distribution Agreement with Applied Tissue Technologies LLC	18-02-21	CI
ACell, Inc. Announces Distribution Agreement with Southmedic, Incorporated	17-01-11	CI
ACell, Inc. Appoints Sally Maher to Board of Directors	16-10-31	CI
ACell, Inc. Names Brad Adams as Vice President of Sales	16-08-22	CI
ACell, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices	16-03-23	CI
ACell, Inc. Announces Management Changes	16-01-11	CI
ACell, Inc. Introduces Cytal Wound Matrix for Complex, Full-Thickness Wounds	16-01-07	CI
ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus	15-05-27	CI
ACell, Inc. Appoints David Elliot as Vice President, Marketing	15-03-15	CI
ACell, Inc. Appoints Thomas Gilbert as a Chief Science Officer	15-01-04	CI
ACell, Inc. Announces Management Changes	14-12-15	CI
ACell, Inc. Announces First Patient in A U.S. Phase IV Clinical Trial	14-07-15	CI

Chart ACell, Inc.

Duration

Period

More charts

Company Profile

ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ACELL, INC.	-.--%	340M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution